Outlook Therapeutics Statistics
Total Valuation
OTLK has a market cap or net worth of $141.44 million. The enterprise value is $160.88 million.
| Market Cap | 141.44M |
| Enterprise Value | 160.88M |
Important Dates
The last earnings date was Friday, August 14, 2026, before market open.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OTLK has 187.00 million shares outstanding. The number of shares has increased by 182.49% in one year.
| Current Share Class | 187.00M |
| Shares Outstanding | 187.00M |
| Shares Change (YoY) | +182.49% |
| Shares Change (QoQ) | +67.09% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 9.54% |
| Float | 162.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -121.68 |
| Forward PS | 8.55 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -210.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.60M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.55M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.49% in the last 52 weeks. The beta is 0.80, so OTLK's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -64.49% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 34.60 |
| Average Volume (20 Days) | 22,532,761 |
Short Selling Information
The latest short interest is 20.01 million, so 10.70% of the outstanding shares have been sold short.
| Short Interest | 20.01M |
| Short Previous Month | 11.24M |
| Short % of Shares Out | 10.70% |
| Short % of Float | 12.32% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
In the last 12 months, OTLK had revenue of -$1.16 million and -$61.12 million in losses. Loss per share was -$0.75.
| Revenue | -1.16M |
| Gross Profit | -2.27M |
| Operating Income | -55.64M |
| Pretax Income | -62.68M |
| Net Income | -61.12M |
| EBITDA | -55.51M |
| EBIT | -55.64M |
| Loss Per Share | -$0.75 |
Balance Sheet
The company has $7.75 million in cash and $27.19 million in debt, with a net cash position of -$19.44 million or -$0.10 per share.
| Cash & Cash Equivalents | 7.75M |
| Total Debt | 27.19M |
| Net Cash | -19.44M |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | -28.99M |
| Book Value Per Share | -0.28 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | -47.05M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 120,988 |
| Net Borrowing | -3.23M |
| Free Cash Flow | -47.05M |
| FCF Per Share | -$0.25 |
Margins
| Gross Margin | n/a |
| Operating Margin | 4,786.01% |
| Pretax Margin | 5,391.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OTLK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -182.49% |
| Shareholder Yield | -182.49% |
| Earnings Yield | -43.21% |
| FCF Yield | -33.26% |
Analyst Forecast
The average price target for OTLK is $5.40, which is 613.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.40 |
| Price Target Difference | 613.91% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 272.92% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 14, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |